Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase

Overview of attention for article published in Digestive Diseases and Sciences, December 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 14 patents

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 14 patents that reference this research output.

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-11865105-B2

United States of America

09 Jan 2024

Sphingosine kinase Type 1 inhibitors and uses thereof

Grant US-11737992-B2

United States of America

29 Aug 2023

Sphingosine kinase type 1 inhibitors and uses thereof

Grant US-10945971-B2

United States of America

16 Mar 2021

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-10881643-B2

United States of America

05 Jan 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 10 additional patents.